EPO and renal cell carcinoma: A previous study demonstrated that EpoR was expressed in kidney tissues removed by nephrectomy or in renal cell carcinoma (RCC) cell lines, and that the proliferation rate of these cells increased with the addition of Epo in a dose-dependent manner (23).